Alteration in contractile response to noradrenaline, 5-hydroxytryptamine, sarafotoxin 6c, and angiotensin II in rat mesenteric artery during organ culture

Academic Journal of Xi'an Jiaotong University

Volumn 16, Issue 2, 2004, Pages 155-159

  Cao, Yongxiao ^a   He, Langchong ^a   Xu, Cangbao ^a   Edvinsson, Lars ^a,b  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Artery; Mesenteric; Organ culture; Rat; Receptor; Vasoconstrictor

Indexed keywords

ANGIOTENSIN; BRADYKININ; ENDOTHELIN 1; NORADRENALIN; SARAFOTOXIN S6C; SEROTONIN; UROTENSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR RESPONSE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; MEDIATOR RELEASE; MESENTERIC ARTERY; NONHUMAN; ORGAN CULTURE; RAT; SMOOTH MUSCLE CONTRACTILITY; VASCULAR DISEASE; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANIMALIA;

EID: 11144331947     PISSN: 16718267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Adner M, Cantera L, Ehlert F, et al. Plasticity of contractile endothelin-B receptors in human arteries after organ culture [J]. Br J Pharmacol, 1996, 119: 1159-1166.
2. Alm R, Edvinsson L, Malmsjö M. Organ culture: a new model for vascular endothelium dysfunction [J]. BMC Cardiovasc Disord, 2002, 2: 8.
3. Ralevic V, Burnstock G. Effects of purines and pyrimidines on the rat mesenteric arterial bed. Circ Res, 1991, 69: 1583-1590.
4. Uddman E, Henriksson M, Eskesen K, et al. Role of mitogen-activated protein kinases in endothelin ETB receptor up-regulation after organ culture of rat mesenteric artery [J]. Eur J Pharmacol, 2003, 482: 39-47.
5. Moller S, Uddman E, Welsh N, et al. Analysis of the time course for organ culture-induced endothelin ET B receptor up-regulation in rat mesenteric arteries [J]. Eur J Pharmacol, 2002, 454: 209-215.
6. Moller S, Edvinsson L, Adner M. Transcriptional regulated plasticity of vascular contractile endothelin ET (B) receptors after organ culture [J]. Eur J Pharmacol, 1997, 329: 69-77.
7. Dagassan PH, Breu V, Clozel M, et al. Upregulation of ET-B receptors in atherosclerotic human coronary arteries [J]. J Cardiovascular Pharmacol, 1996, 27: 147-153.
8. Wackenfors A, Emilson M, Ingemansson R, et al. Ischemic heart disease induce upregulation of endothelin receptor mRNA in human coronary arteries [J]. Eur J Pharmacol, 2004, 484: 103-109.
9. Lobato RD, Marin J, Salaices M, et al. Cerebrovascular reactivity to noradrenaline and serotonin following experimental subarachnoid hemorrhage [J]. J Neurosurg, 1980, 53: 480-485.
10. Svendgaard NA, Edvinsson L, Owman C, Sahlin C. Increased sensitivity of the basilar artery to norepinephrine and 5-hydroxytryptamine following experimental subarachnoid hemorrhage. Surg Neurol 1977, 8: 191-195.
11. Hansen-Schwartz J, Svensson CL, Xu CB. Protein kinase mediated upregulation of endothelin A, B and 5-hydroxytryptamine 1B/1D receptors during organ culture in rat basilar artery [J]. Br J Pharmacol, 2002, 137: 118-126.
12. 1B receptor in cerebral arteries in rats [J]. J Neurosurg, 2003, 99: 115-120.
13. Douglas SA, Ohlstein EH. Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiaovascular disease [J]. Trends Cardiovasc Med, 2000, 10: 229-237.
14. Ames RS, Sarau HM, Chambers JK, et al. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 [J]. Nature, 1999, 401: 282-286.
15. Hillier C, Berry C, O'Dwyer PJ, et al. Effects of urotensin II in human arteries and veins of varying caliber [J]. Circulation, 2001, 103: 1378-1381.
16. Pompermayer K, Assreuy J, Maria ARV. Involvement of nitric oxide and potassium channels in the bradykinin-induced vasodilatation in the rat kidney perfused ex situ [J]. Regulatory Peptides, 2002, 105: 155-162.